8+ hour, 45+ min ago   (414+ words) MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Pixclara® (floretyrosine F 18 or 18F-FET),…...

3+ day, 23+ hour ago   (104+ words) Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist PNOC035 is conducted by the Pediatric Neuro-Oncology Consortium (PNOC), an open-label, multi-center platform study. In Arm A,…...

5+ day, 1+ hour ago   (135+ words) The IND clearance marks the transition of the first-in-class new drug from preclinical research into clinical development. IgA Nephropathy and Unmet Medical Need [1] Shen X, Shu C, Dong Y, et al. Therapeutic efficacy and antigenicity of a novel PEGylated IgA…...

6+ day, 15+ hour ago   (126+ words) KUALA LUMPUR, Malaysia, Sept. 7, 2026 /PRNewswire/ — Ddrops® brought together Damansara Specialist Hospital, recognised among the World’s Best Hospitals (2026) powered by Statista, and Motherhood.com.my, Malaysia’s #1 trusted parenting platform, for a health education forum focused on translating science-backed vitamin D insights…...

1+ week, 2+ day ago   (106+ words) SHANGHAI, Sept. 4, 2026 /PRNewswire/ — Carestream Healthcare International is introducing the latest version of its DRX‑LC Detector, delivering enhanced imaging performance, efficiency, and quality for long‑length imaging across a wide range of exams and clinical environments. These advancements improve dose…...

1+ week, 5+ day ago   (173+ words) Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX) is a commercial-stage global radiopharmaceutical company, advancing targeted theranostics to improve outcomes for people with cancer across the patient journey. Theranostics pairs a precision diagnostic with a targeted therapy to both diagnose and treat…...

1+ week, 6+ day ago   (347+ words) – Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada. – Global Phase III clinical program to investigate efficacy and safety of three maintenance doses (20 mg, 40 mg, and 60 mg)…...

2+ week, 3+ day ago   (271+ words) Macau Business Exascend Deploys Advanced Medical-Grade Storage Solutions to Power Next-Generation Healthcare Systems TAIPEI, Aug. 27, 2026 /PRNewswire/ — Exascend announced the successful deployment of its Medical-Grade Storage Solutions in collaboration with a leading healthcare technology provider, supporting the demanding requirements of next-generation…...

2+ week, 5+ day ago   (116+ words) ATG-201 is a CD19 targeting bispecific TCE incorporating steric hindrance masking technology, designed to eliminate CD19-expressing B cells. This bispecific interaction with T and B cells through CD3 and CD19 has demonstrated potential in treating B cell-driven diseases by leveraging the body’s own…...

2+ week, 5+ day ago   (408+ words) The one-day course, titled “Airway & Growth,” was led by Dr Yue Weng Cheu, Clinical Director of DP Dental in Singapore, who led the key clinical collaborators involved in the development of AG KIDS. The program opened with clinical cases illustrating…...